Take Part in Groundbreaking Alopecia Areata Research In NYC

Are you or someone you know struggling with severe alopecia areata (AA)? This autoimmune condition attacks hair follicles, leading to hair loss across the body, particularly on the head and face. Join our clinical trial to advance research in treating AA in NYC. By participating, you’ll receive expert care and monitoring while also contributing to medical progress that could transform lives.

This study evaluates Rinvoq’s safety, effectiveness, and tolerability in adolescents and adults with severe AA. Participants will receive compensation. Seize this chance to make a difference—sign up today and help shape the future of alopecia areata treatment!

New York location for dermatology study by Equity Medical
Study Location
New York
Office Address

200 Amsterdam Ave. New York, NY 10023

Office Phone
646-413-6020

Overview

Recruiting start date
  • 9/1/24
Duration
  • 24 Weeks
Population

Age 12 years and older with Severe Alopecia Areata (SALT score ≥ 50, ie 50% scalp hair loss).

Study Drug

Rinvoq 15 or 30 mg tablet QD (80%) or placebo (20%). Subjects initially randomized to placebo who do not respond will be re-randomized to Rinvoq after completion of the Week 24 visit.

Inclusion Criteria
  • Diagnosis of severe AA with a current episode of alopecia areata of less than 8 years.
  • No spontaneous scalp hair regrowth over the past 6 months
  • Less than 12 weeks of previous failed JAK exposure with treatment
Exclusion Criteria
  • Current diagnosis of primarily diffuse type of alopecia areata (AA).
  • Current diagnosis of other types of alopecia that would interfere with evaluation of AA, including but not limited to female pattern hair loss, male pattern hair loss (androgenetic alopecia) Stage III or greater based on Hamilton-Norwood classification, traction alopecia, lichen planopilaris (LPP), discoid lupus, frontal fibrosing alopecia (FFA), central centrifugal cicatricial alopecia (CCCA), folliculitis decalvans, trichotillomania, and telogen effluvium.
  • Diagnosis of other types of inflammatory scalp, eyebrow, or eyelash disorders that would interfere with evaluation of AA as determined by the investigator.
Compensation
  • Participants will receive $75 per visit
Studies
Contact us to join a dermatology study clinical trial

Contact Us Today!

Whether it be eczema, dandruff, or psoriasis, being a part of our research is an impactful way to explore treatments and medications. Even if there isn’t a current study that’s a perfect fit for you, take the first step and sign up to learn more and be considered for future studies in New York and Kentucky. Click the button below to get started!